These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2903355)

  • 1. Safety of pasteurised factor VIII (haemate HS).
    Delvos V; Weidmann E; Hilfenhaus J; Mauler R
    Lancet; 1988 Nov; 2(8620):1141-2. PubMed ID: 2903355
    [No Abstract]   [Full Text] [Related]  

  • 2. [Advances in hemophilia treatment: a hepatitis-safe factor VIII concentrate].
    Heimburger N
    Blut; 1982 Apr; 44(4):249-51. PubMed ID: 6805537
    [No Abstract]   [Full Text] [Related]  

  • 3. [Plasma concentrates of factor VIII. Where are we?].
    Vicente V
    Sangre (Barc); 1989 Feb; 34(1):1-3. PubMed ID: 2496481
    [No Abstract]   [Full Text] [Related]  

  • 4. Virucidal treatment of clotting factor concentrates.
    Mannucci PM; Colombo M
    Lancet; 1988 Oct; 2(8614):782-5. PubMed ID: 2901620
    [No Abstract]   [Full Text] [Related]  

  • 5. Viral safety issues: plasma-derived factor VIII.
    Berntorp E
    Ann Hematol; 1994; 68 Suppl 3():S35-6. PubMed ID: 8180256
    [No Abstract]   [Full Text] [Related]  

  • 6. Transmission of hepatitis C with pasteurised factor VIII.
    Schulman S; Lindgren AC; Petrini P; Allander T
    Lancet; 1992 Aug; 340(8814):305-6. PubMed ID: 1353214
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of hemophilia with factor VIII concentrates.
    Agarwal MB; Mehta BC
    Indian J Med Sci; 1980 Sep; 34(9):226-30. PubMed ID: 6782019
    [No Abstract]   [Full Text] [Related]  

  • 8. Factor VIII cryoprecipitate and hepatitis risk.
    Gabra GS; Crawford RJ; Mitchell R
    Lancet; 1982 Nov; 2(8309):1220. PubMed ID: 6128524
    [No Abstract]   [Full Text] [Related]  

  • 9. Justice versus equity for haemophiliacs with AIDS.
    Ablin RJ
    BMJ; 1990 Nov; 301(6761):1165. PubMed ID: 2123722
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibody to hepatitis C virus after a vapour-heated factor VIII concentrate. The Study Group of the Fondazione dell'Emofilia.
    Mannucci PM; Zanetti AR; Colombo M; Chistolini A; De Biasi R; Musso R; Tamponi G
    Thromb Haemost; 1990 Oct; 64(2):232-4. PubMed ID: 2176748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purity of concentrates for substitution therapy: acceptable and undesirable contaminants--Madrid 1978.
    Scand J Haematol Suppl; 1980; 35():65-89. PubMed ID: 6770460
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum hepatitis in a haemophiliac.
    Fitzpatrick J; Kennedy CC
    Br Med J; 1969 Nov; 4(5678):299. PubMed ID: 5345943
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic properties and safety of recombinant factor VIII and factor IX.
    Zdziarska J; Chojnowski K; Klukowska A; Łetowska M; Mital A; Podolak-Dawidziak M; Windyga J; Zawilska K;
    Pol Arch Med Wewn; 2009 Jun; 119(6):403-9. PubMed ID: 19694223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From the Centers for Disease Control and Prevention. Hepatitis A among persons with hemophilia who received clotting factor concentrate--United States, September-December 1995.
    JAMA; 1996 Feb; 275(6):427-8. PubMed ID: 8627951
    [No Abstract]   [Full Text] [Related]  

  • 15. HIV seroconversion in haemophilic boys receiving heat-treated factor VIII concentrate.
    Williams MD; Skidmore SJ; Hill FG
    Vox Sang; 1990; 58(2):135-6. PubMed ID: 2111060
    [No Abstract]   [Full Text] [Related]  

  • 16. Transmission of hepatitis B by dry heat treated factor VIII and IX concentrates.
    Lush CJ; Chapman CS; Mitchell VE; Martin C
    Br J Haematol; 1988 Jul; 69(3):421. PubMed ID: 3136793
    [No Abstract]   [Full Text] [Related]  

  • 17. Transmission of hepatitis C virus by monoclonal-purified viral-attenuated factor VIII concentrate.
    Kessler C; Lusher J; Pierce GF; Pierce B; Koerper MA; Dickinson JC
    Lancet; 1995 Nov; 346(8985):1297-8. PubMed ID: 7475738
    [No Abstract]   [Full Text] [Related]  

  • 18. Transmission of hepatitis C virus by monoclonal-purified viral-attenuated factor VIII concentrate.
    Bergman GE
    Lancet; 1995 Nov; 346(8985):1296-7. PubMed ID: 7475737
    [No Abstract]   [Full Text] [Related]  

  • 19. Preliminary clinical experience: pharmacokinetics and tolerance of a double-virus-inactivated factor VIII preparation.
    Martinowitz U
    Blood Coagul Fibrinolysis; 1995 Jul; 6 Suppl 2():S84-5. PubMed ID: 7495976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human plasma von Willebrand factor/factor VIII complex (Haemate P/Humate-P): in von Willebrand disease and haemophilia A.
    Carter NJ; Scott LJ
    Drugs; 2007; 67(10):1513-9. PubMed ID: 17600395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.